b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">\n        <PMID Version="1">31443247</PMID>\n        <DateRevised>\n            <Year>2020</Year>\n            <Month>02</Month>\n            <Day>25</Day>\n        </DateRevised>\n        <Article PubModel="Electronic">\n            <Journal>\n                <ISSN IssnType="Print">2072-6694</ISSN>\n                <JournalIssue CitedMedium="Print">\n                    <Volume>11</Volume>\n                    <Issue>8</Issue>\n                    <PubDate>\n                        <Year>2019</Year>\n                        <Month>Aug</Month>\n                        <Day>15</Day>\n                    </PubDate>\n                </JournalIssue>\n                <Title>Cancers</Title>\n                <ISOAbbreviation>Cancers (Basel)</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>Targeted Treatment Options of Recurrent Radioactive Iodine Refractory H\xc3\xbcrthle Cell Cancer.</ArticleTitle>\n            <ELocationID EIdType="pii" ValidYN="Y">E1185</ELocationID>\n            <ELocationID EIdType="doi" ValidYN="Y">10.3390/cancers11081185</ELocationID>\n            <Abstract>\n                <AbstractText><i>Objective</i>: To evaluate the efficacy and treatment rationale of H\xc3\xbcrthle cell carcinoma (HCC) following a patient with progressive and metastatic HCC. HCC was recently shown to harbor a distinct genetic make-up and the mitogen-activated protein kinase (MAPK) and phosphatidylinositol 3-kiase (PI3K)/AKT signaling pathways are potential targets for anti-cancer agents in the management of recurrent HCC. The presence or absence of gene variants can give a rationale for targeted therapies that could be made available in the context of drug repurposing trials. <i>Methods:</i> Treatment included everolimus, sorafenib, nintedanib, lenvatinib, and panitumumab. Whole genome sequencing (WGS) of metastatic tumor material obtained before administration of the last drug, was performed. We subsequently evaluated the rationale and efficacy of panitumumab in thyroid cancer and control cell lines after epidermal growth factor (EGF) stimulation and treatment with panitumumab using immunofluorescent Western blot analysis. EGF receptor (EGFR) quantification was performed using flow cytometry. <i>Results:</i> WGS revealed a near-homozygous genome (NHG) and a somatic homozygous <i>TSC1</i> variant, that was absent in the primary tumor. In the absence of <i>RAS</i> variants, panitumumab showed no real-life efficacy. This might be explained by high constitutive AKT signaling in the two thyroid cancer cell lines with NHG, with panitumumab only being a potent inhibitor of pEGFR in all cancer cell lines tested. <i>Conclusions:</i> In progressive HCC, several treatment options outside or inside clinical trials are available. WGS of metastatic tumors might direct the timing of therapy. Unlike other cancers, the absence of <i>RAS</i> variants seems to provide insufficient justification of single-agent panitumumab administration in HCC cases harboring a near-homozygous genome.</AbstractText>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Aydemirli</LastName>\n                    <ForeName>Mehtap Derya</ForeName>\n                    <Initials>MD</Initials>\n                    <Identifier Source="ORCID">0000-0003-2891-7059</Identifier>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Medical Oncolosgy, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Corver</LastName>\n                    <ForeName>Willem</ForeName>\n                    <Initials>W</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Pathology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Beuk</LastName>\n                    <ForeName>Ruben</ForeName>\n                    <Initials>R</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Pathology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Roepman</LastName>\n                    <ForeName>Paul</ForeName>\n                    <Initials>P</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Hartwig Medical Foundation, 1098 XH Amsterdam, The Netherlands.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Solleveld-Westerink</LastName>\n                    <ForeName>Nienke</ForeName>\n                    <Initials>N</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Pathology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>van Wezel</LastName>\n                    <ForeName>Tom</ForeName>\n                    <Initials>T</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Pathology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Kapiteijn</LastName>\n                    <ForeName>Ellen</ForeName>\n                    <Initials>E</Initials>\n                    <Identifier Source="ORCID">0000-0002-4814-6426</Identifier>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Medical Oncolosgy, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands. h.w.kapiteijn@lumc.nl.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Morreau</LastName>\n                    <ForeName>Hans</ForeName>\n                    <Initials>H</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Pathology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands. j.morreau@lumc.nl.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n            </PublicationTypeList>\n            <ArticleDate DateType="Electronic">\n                <Year>2019</Year>\n                <Month>08</Month>\n                <Day>15</Day>\n            </ArticleDate>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>Switzerland</Country>\n            <MedlineTA>Cancers (Basel)</MedlineTA>\n            <NlmUniqueID>101526829</NlmUniqueID>\n            <ISSNLinking>2072-6694</ISSNLinking>\n        </MedlineJournalInfo>\n        <KeywordList Owner="NOTNLM">\n            <Keyword MajorTopicYN="N">AKT</Keyword>\n            <Keyword MajorTopicYN="N">H\xc3\xbcrthle cell carcinoma</Keyword>\n            <Keyword MajorTopicYN="N">cell line</Keyword>\n            <Keyword MajorTopicYN="N">cell signaling</Keyword>\n            <Keyword MajorTopicYN="N">epidermal growth factor receptor</Keyword>\n            <Keyword MajorTopicYN="N">humans</Keyword>\n            <Keyword MajorTopicYN="N">near-homozygous genome</Keyword>\n            <Keyword MajorTopicYN="N">panitumumab</Keyword>\n            <Keyword MajorTopicYN="N">targeted therapy</Keyword>\n            <Keyword MajorTopicYN="N">thyroid neoplasm</Keyword>\n            <Keyword MajorTopicYN="N">tumor</Keyword>\n        </KeywordList>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="received">\n                <Year>2019</Year>\n                <Month>07</Month>\n                <Day>30</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="accepted">\n                <Year>2019</Year>\n                <Month>08</Month>\n                <Day>13</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2019</Year>\n                <Month>8</Month>\n                <Day>25</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2019</Year>\n                <Month>8</Month>\n                <Day>25</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2019</Year>\n                <Month>8</Month>\n                <Day>25</Day>\n                <Hour>6</Hour>\n                <Minute>1</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>epublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">31443247</ArticleId>\n            <ArticleId IdType="pii">cancers11081185</ArticleId>\n            <ArticleId IdType="doi">10.3390/cancers11081185</ArticleId>\n            <ArticleId IdType="pmc">PMC6721552</ArticleId>\n        </ArticleIdList>\n        <ReferenceList>\n            <Reference>\n                <Citation>Thyroid. 2001 Oct;11(10):909-17</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">11716037</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Clin Endocrinol Metab. 2002 Oct;87(10):4595-601</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">12364440</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Clin Endocrinol Metab. 2003 May;88(5):2318-26</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">12727991</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cancer Res. 1992 Sep 15;52(18):5061-4</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">1516062</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Clin Oncol. 2005 Apr 10;23(11):2445-59</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">15753456</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Clin Invest. 2005 Apr;115(4):1068-81</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">15761501</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Clin Endocrinol Metab. 2006 Aug;91(8):2892-9</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">16684830</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Proc Natl Acad Sci U S A. 2007 May 22;104(21):9001-6</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">17517629</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Clin Endocrinol Metab. 2008 Feb;93(2):611-8</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">18000091</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>N Engl J Med. 2008 Jan 10;358(2):140-51</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">18184959</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Clin Endocrinol Metab. 2008 Aug;93(8):3106-16</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">18492751</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Clin Endocrinol Metab. 2008 Nov;93(11):4331-41</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">18713817</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Eur J Surg Oncol. 2009 Mar;35(3):230-4</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">18722077</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Eur J Cancer. 2009 Jan;45(2):228-47</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">19097774</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Clin Oncol. 2009 Apr 20;27(12):2091-6</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">19188670</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cancer Res. 2009 Jun 1;69(11):4885-93</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">19487299</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Clin Oncol. 2010 Feb 10;28(5):835-40</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">20048174</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Biol Chem. 1991 Apr 25;266(12):7503-8</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">2019581</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Clin Oncol. 2011 Feb 20;29(6):e150-3</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">21189378</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Mod Pathol. 2011 Apr;24 Suppl 2:S34-43</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">21455199</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Clin Cancer Res. 2011 Jun 15;17(12):4071-81</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">21525172</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Endocr Relat Cancer. 2012 Jul 18;19(4):R131-47</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22514109</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>PLoS One. 2012;7(6):e38287</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22675538</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cancer. 2013 Feb 1;119(3):504-11</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22893587</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Eur J Endocrinol. 2012 Nov;167(5):643-50</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22918300</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Science. 2012 Oct 12;338(6104):221</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22923433</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Oncotarget. 2012 Sep;3(9):954-87</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23006971</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Expert Rev Anticancer Ther. 2012 Sep;12(9):1137-47</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23098114</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Genes Cancer. 2012 Jul;3(7-8):459-66</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23264846</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Nat Rev Cancer. 2013 Mar;13(3):184-99</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23429735</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Clin Endocrinol Metab. 2013 May;98(5):E962-72</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23543667</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Clin Endocrinol Metab. 2013 Sep;98(9):E1562-6</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23833040</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Ann Oncol. 2013 Dec;24(12):3089-94</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24050953</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cancer Discov. 2014 May;4(5):554-63</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24631838</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Lancet. 2014 Jul 26;384(9940):319-28</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24768112</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Lancet Diabetes Endocrinol. 2014 May;2(5):356-8</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24795243</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Genes Chromosomes Cancer. 2014 Oct;53(10):833-44</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24909752</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>N Engl J Med. 2014 Oct 9;371(15):1426-33</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25295501</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>BMC Cancer. 2014 Oct 23;14:777</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25338674</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>N Engl J Med. 2015 Feb 12;372(7):621-30</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25671254</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Thyroid. 2016 Jan;26(1):1-133</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26462967</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Front Endocrinol (Lausanne). 2016 Jan 11;6:188</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26793165</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Oncotarget. 2016 Mar 1;7(9):10547-56</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26859683</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Hum Mutat. 2016 Jun;37(6):564-9</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26931183</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Horm Cancer. 2016 Jun;7(3):188-95</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26994002</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Clin Endocrinol Metab. 2017 Feb 1;102(2):698-707</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27870581</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>JAMA. 2017 Apr 4;317(13):1338-1348</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28362912</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>BMC Cancer. 2017 May 25;17(1):371</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28545571</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Target Oncol. 2017 Oct;12(5):571-597</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28815409</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Best Pract Res Clin Endocrinol Metab. 2017 Jun;31(3):349-361</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28911730</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Endocr Relat Cancer. 2018 Jan;25(1):83-97</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29066502</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Lancet Diabetes Endocrinol. 2018 Jun;6(6):500-514</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29102432</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Front Endocrinol (Lausanne). 2017 Nov 20;8:312</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29209273</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Histopathology. 2018 Jan;72(1):6-31</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29239040</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Endocr Relat Cancer. 2018 Apr;25(4):R209-R223</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29371330</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Clin Cancer Res. 2018 Jul 1;24(13):3059-3068</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29615459</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Endocr Relat Cancer. 2018 Jun;25(6):699-704</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29752332</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cancer Cell. 2018 Aug 13;34(2):242-255.e5</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">30107175</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cancer Cell. 2018 Aug 13;34(2):256-270.e5</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">30107176</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Endocr Relat Cancer. 2018 Dec 1;:null</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">30576283</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Thyroid. 2019 Apr;29(4):471-479</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">30848171</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Natl Cancer Inst. 1973 Nov;51(5):1417-23</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">4357758</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Virol. 1995 Jul;69(7):4390-8</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">7769701</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Clin Endocrinol Metab. 1994 Sep;79(3):806-13</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">8077365</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Clin Endocrinol Metab. 1997 Aug;82(8):2633-8</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">9253346</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Thyroid. 1998 Jun;8(6):475-83</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">9669284</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Virchows Arch. 1998 Jul;433(1):5-12</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">9692819</ArticleId>\n                </ArticleIdList>\n            </Reference>\n        </ReferenceList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'